144
Participants
Start Date
May 1, 2025
Primary Completion Date
April 30, 2027
Study Completion Date
November 30, 2027
Nicotinamide Riboside
Oral Nicotinamide Riboside, 2g daily for 4 weeks followed by 1g daily for 16 weeks
Placebo
Matched placebo
Vitrectomy and Gas tamponade
Standard of care Vitrectomy surgery for retinal reattachment
Centre for Eye Research Australia, East Melbourne
Cerulea, East Melbourne
The Royal Victorian Eye and Ear Hospital, East Melbourne
Dr David Fabinyi, Geelong
Dr David Sousa, Geelong
Lead Sponsor
Center for Eye Research Australia
OTHER